Karyopharm Therapeutics Inc (KPTI) stock is down 2.86% over the past week and gets a Bearish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With KPTI Stock Today?
Karyopharm Therapeutics Inc (KPTI) stock is lower by -3.48% while the S&P 500 has gained 1.04% as of 1:49 PM on Thursday, Apr 15. KPTI has fallen -$0.35 from the previous closing price of $10.20 on volume of 2,681,326 shares. Over the past year the S&P 500 is up 46.44% while KPTI has fallen -54.71%. KPTI lost -$2.72 per share in the over the last 12 months.
More About Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc is a pharmaceutical company. The company focused on the discovery, development, and commercialization of medicines with the goal of improving the lives of patients with cancer.